Mycolactone subverts immunity by selectively blocking the sec61 translocon, J. Exp. Med, vol.213, pp.2885-2896, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01432024
Lost but making progress-Where will new analgesic drugs come from?, Sci. Transl. Med, vol.6, pp.249-252, 2014. ,
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease, PLoS Negl. Trop. Dis, vol.8, 2014. ,
Pharmacogenetics of analgesic drugs, Br. J. Pain, vol.7, pp.189-208, 2013. ,
Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study, Infect. Immun, vol.76, 2002. ,
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, Science, vol.283, pp.854-857, 1999. ,
Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer, Am. J. Pathol, vol.168, pp.805-811, 2006. ,
Shaping mycolactone for therapeutic use against inflammatory disorders, Sci. Transl. Med, vol.7, pp.289-85, 2015. ,
Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in buruli ulcer, Biochem. Soc. Trans, vol.42, pp.177-183, 2014. ,
The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER, PLoS Pathog, vol.10, p.1004061, 2014. ,
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, vol.32, pp.77-88, 1988. ,
Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulcerans, Chem. Commun, vol.21, pp.2822-2823, 2003. ,
Mycolactone displays anti-inflammatory effects on the nervous system, PLoS Negl. Trop. Dis, vol.11, p.6058, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01664214
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control, PLoS Med, vol.2, p.108, 2005. ,
Clinical features of spontaneous partial healing during Mycobacterium ulcerans infection, Open Forum Infect. Dis, vol.3, p.13, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01281366
FVB/N mice spontaneously heal ulcerative lesions induced by Mycobacterium ulcerans and switch M. ulcerans into a low mycolactone producer, J. Immunol, vol.196, pp.2690-2698, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01284881
Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage, PLoS One, vol.7, p.33600, 2012. ,
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways, Cell, vol.157, pp.1565-1576, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01117565
Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin, Int. J. Antimicrob. Agents, vol.22, pp.240-241, 2003. ,
Pain market, Nat. Rev. Drug. Discov, vol.9, pp.589-590, 2010. ,
Proteomics reveals scope of mycolactone-mediated sec61 blockade and distinctive stress signature, Mol. Cell. Proteo, vol.17, pp.1750-1765, 2018. ,
Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4, Cell Death Dis, vol.3, pp.397-412, 2018. ,
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease, PLoS Negl. Trop. Dis, vol.7, p.2101, 2013. ,
Mycolactone diffuses into the peripheral blood of buruli ulcer patients-implications for diagnosis and disease monitoring, PLoS Negl. Trop. Dis, vol.5, p.1237, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00691438
Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/buruli ulcer disease, Cell. Microbiol, vol.18, pp.17-29, 2016. ,
Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease, BMC Infect. Dis, vol.14, p.202, 2014. ,
Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy, Pharm. Res, vol.31, pp.1605-1615, 2014. ,
Mycobacterium ulcerans infection: control, diagnosis, and treatment, Lancet. Infect. Dis, vol.6, pp.288-296, 2006. ,
A bacterial toxin with analgesic properties: hyperpolarization of DRG neurons by mycolactone, Toxins, vol.9, p.227, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01582485
The future of pain research, Science, vol.354, pp.564-565, 2016. ,
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study, Lancet Glob. Health, vol.2, issue.14, pp.70223-70225, 2014. ,
, Conflict of Interest Statement: The authors declare that the research was
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, 2019. ,